Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02385708Completed
Randomised, open-label trial of chlorhexidine in surgical site infection (SSI) (2 arms), sponsored by Vanderbilt University. Primary endpoint: Incidence of Surgical Site Infections at 30 days. Started Aug 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02385708.